0001209191-22-062808.txt : 20221228 0001209191-22-062808.hdr.sgml : 20221228 20221228160011 ACCESSION NUMBER: 0001209191-22-062808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221223 FILED AS OF DATE: 20221228 DATE AS OF CHANGE: 20221228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iyengar Vijay K CENTRAL INDEX KEY: 0001670000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 221494381 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-23 0 0000879169 INCYTE CORP INCY 0001670000 Iyengar Vijay K 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, GMAPPS Common Stock 2022-12-23 4 M 0 7866 72.86 A 48179 D Common Stock 2022-12-23 4 S 0 7866 80.80 D 40313 D Common Stock 2022-12-23 4 M 0 7000 68.62 A 47313 D Common Stock 2022-12-23 4 S 0 7000 80.80 D 40313 D Common Stock 2022-12-23 4 S 0 804 80.77 D 39509 D Common Stock 2022-12-23 4 S 0 1654 80.79 D 37855 D Non-Qualified Stock Option (right to buy) 72.86 2022-12-23 4 M 0 7866 0.00 D 2023-05-08 Common Stock 7866 0 D Non-Qualified Stock Option (right to buy) 68.62 2022-12-23 4 M 0 7000 0.00 D 2028-07-01 Common Stock 7000 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Includes an aggregate of 35,198 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Beginning May 9, 2016, options become exercisable in 25 installments, with the first 33.33% vesting on May 9, 2017 and the remainder vesting monthly over two years. Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. /s/ Elizabeth Feeney, Attorney-In-Fact 2022-12-28